MedTrace Logo

A Smoking Cessation Study to Understand the Biological and Functional Changes After One Year of Smoking Cessation

NCT02432729 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1184

Last updated 2023-01-30

Study results available
· View outcomes & findings →

Summary

The purpose of this study was to understand the biological and functional changes after one year of smoking cessation and to collect data on a broad range of biomarkers of exposure (BoExp) and biomarkers of effect (BoE).

Conditions

  • Cigarette Smoking

Sponsors & Collaborators

  • Philip Morris Products S.A.

    lead INDUSTRY

Principal Investigators

  • Christelle Haziza, PhD · Philip Morris Products S.A.

  • Christel Contzen, MD · Synexus Clinical Research GmbH

  • Monika Tomaszewska-Kiecana, MD · BioVirtus Research Site Sp. z o.o.

  • Susannah Eyre, MD · Synexus, Merseyside Clinical Research Centre

  • Jed Rose, PhD · Rose Research Center

  • Koichi Nakamura, MD · Clinical Research Tokyo Hospital

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-05-05
Primary Completion
2017-05-31
Completion
2018-04-27

Countries

  • United States
  • Germany
  • Japan
  • Poland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02432729 on ClinicalTrials.gov